Fingerprint
Dive into the research topics of 'Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes
Ildiko Lingvay, Nadine Beetz, Regina Sennewald, Annette Schuler-Metz, Julia Bertulis, Christina Loley, Benjamin Lang, Caroline Lippert, Jisoo Lee, Linda Shapiro Manning, Derek Terada
Research output: Contribution to journal › Article › peer-review
15
Scopus
citations